**Core Concept**
Electroconvulsive therapy (ECT) is a psychiatric treatment that involves the application of electrical impulses to induce seizures in patients with severe or treatment-resistant depression. The therapeutic efficacy of ECT is thought to be related to the changes it induces in brain neurotransmitter systems, particularly the regulation of excitatory and inhibitory neurotransmitters.

**Why the Correct Answer is Right**
The maximum benefit of ECT is seen in patients with severe, treatment-resistant depression, particularly those who have not responded to other treatments such as pharmacotherapy or psychotherapy. The therapeutic effect of ECT is thought to be due to the increased release of neurotransmitters such as norepinephrine, serotonin, and acetylcholine, which helps to increase the levels of these neurotransmitters in the synaptic cleft. This is particularly beneficial for patients with severe depression who have a decreased level of these neurotransmitters.

**Why Each Wrong Option is Incorrect**
**Option A:** ECT is not typically used as a first-line treatment for mild depression, as its side effects and risks outweigh its benefits in these cases.
**Option B:** While ECT can be used in patients with bipolar disorder, its maximum benefit is not seen in this population, particularly when compared to patients with unipolar depression.
**Option C:** ECT is not typically used as a treatment for anxiety disorders, despite its potential benefits in reducing anxiety symptoms.

**Clinical Pearl / High-Yield Fact**
ECT is a highly effective treatment for severe depression, with response rates ranging from 50-80%, particularly in patients who have not responded to other treatments.

**Correct Answer:** C. Patients with severe, treatment-resistant depression.